A Closer Look at Spravato (Esketamine)

A Closer Look at Spravato (Esketamine)

Podcast: A Closer Look at Spravato (Esketamine) – Does Spravato require patients to be prescribed an antidepressant? 

A closer look at Spravato/Esketamine. This episode focuses on the definition of Treatment Resistant Depression and looks at whether patients must be prescribed to an antidepressant while using Spravato. Additionally, what does one do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? 

Read More →
A Closer Look at Spravato (Esketamine)

Podcast: A Closer Look at Spravato (Esketamine) – What do we know about the prescribed dosing?

One thing that raised the eyebrows of everybody on the clinical team here at KWC relates to the recommended dosing of Spravato. On this episode, we discuss what the recommended dosing is during the stabilization and maintenance treatment phases. Is the dosing variable from patient to patient or fixed? What are the implications of utilizing a non-variable prescription for dosing?

Read More →
A Closer Look at Spravato (Esketamine)

Podcast: A Closer Look at Spravato (Esketamine) – What will the drug cost and will insurance cover it?

This episode focuses on the cost of Spravato to the provide, end user, and insurer. What are the preliminary cost estimates for Spravato (wholesale)? Can we estimate the cost to the patient? Will insurance cover the drug? How will the treatment schedule effect the cost?

Read More →
A Closer Look at Spravato (Esketamine)

Podcast: A Closer Look at Spravato (Esketamine) – How will it be administered?

This episode focuses on how Spravato is administered. Is intranasal delivery effective? What type of clinical environments can provide Spravato to patients? What duration of time will patients have to commit to treatment?

Read More →